UnitedHealth Group Incorporated UNH NYSE

UnitedHealth Group Incorporated (UNH) has shown strong revenue growth over the past 3 years, expanding from $322.1B to $447.6B (average +11.6%/yr). Net income reached $12.1B, reflecting earnings decline at -13.6%/yr on average. The net profit margin is 2.7%, which is thin. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 18.5% (low), with a -5.6pp trend over the period. With a $285B market cap and MOAT composite score of 51/100, the company has a moderate competitive position.

Criteria proven by this page:

• GROWTH (48/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 41-year history, the company was profitable in 38 of 41 years — an excellent long-term track record
• INCOME (30/100, Partial) — the company is profitable but margin is below 15%
• MOAT (51/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 58/100 with 3/7 criteria passed.